Intec Pharma To Raise $46M In IPO

June 11, 2015 | The Israeli pharmaceutical company developing a leading Parkinson’s drug, Intec Pharma filed a prospectus with the US SEC to raise up to $46 million in an IPO. Intec Pharma is already traded publicly on the TASE with a market cap of $44 million. Intec Pharma is based in Jerusalem and was founded in 2000.